| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 08, 2026 |
BioNTech SE - ADR
BNTX
|
BUY |
$105.00
Est. +1%
|
$103.76 | $103.00 |
Precision Hit (±3%)
|
$98.57
-5.0%
|
| Jul 01, 2026 |
AMGEN Inc.
AMGN
|
BUY |
$400.00
Est. +10%
|
$362.45 | $447.01 |
Target Met
|
$423.64
+16.9%
|
| Jun 22, 2026 |
Incyte Corp.
INCY
|
SELL |
$94.00
Est. +4%
|
$98.22 | $99.79 (Low) |
Pending
|
$123.20
-25.4%
|
| Mar 11, 2026 |
BioNTech SE - ADR
BNTX
|
BUY |
$128.00
Est. +41%
|
$90.52 | $116.87 |
Pending
|
$98.57
+8.9%
|
| Mar 09, 2026 |
Pfizer Inc.
PFE
|
BUY |
$30.00
Est. +13%
|
$26.49 | $29.21 |
Precision Hit (±3%)
|
$28.73
+8.4%
|
| Mar 02, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$600.00
Est. +23%
|
$487.57 | $560.25 |
Pending
|
$526.73
+8.0%
|
| Jan 26, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$150.00
Est. +9%
|
$137.01 | $157.27 |
Target Met
|
$151.28
+10.4%
|
| Jan 15, 2026 |
Abbvie Inc
ABBV
|
BUY |
$258.00
Est. +18%
|
$217.74 | $269.39 |
Target Met
|
$263.25
+20.9%
|
| Nov 25, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$135.00
Est. +6%
|
$127.57 | $157.27 |
Target Met
|
$151.28
+18.6%
|
| Oct 31, 2025 |
Merus N.V
MRUS
|
BUY |
$97.00
Est. +2%
|
$94.90 | $97.02 |
Bullseye Hit (±1%)
|
$90.00
-5.2%
|
| Nov 12, 2024 |
Abbvie Inc
ABBV
|
BUY |
$208.00
Est. +3%
|
$201.61 | $244.81 |
Target Met
|
$263.25
+30.6%
|
| Nov 05, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$112.00
Est. +77%
|
$63.24 | $95.95 |
Miss
|
$65.87
+4.2%
|
| Nov 01, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,190.00
Est. +41%
|
$843.60 | $862.00 |
Miss
|
$750.51
-11.0%
|
| Nov 01, 2024 |
Merck & Co Inc
MRK
|
BUY |
$136.00
Est. +33%
|
$101.88 | $105.07 |
Miss
|
$149.32
+46.6%
|
| Nov 01, 2024 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$57.00
Est. +5%
|
$54.32 | $63.33 |
Target Met
|
$62.86
+15.7%
|
| Oct 31, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,010.00
Est. +22%
|
$829.74 | $935.63 |
Miss
|
$1,186.10
+42.9%
|
| Oct 31, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$121.00
Est. +1%
|
$120.27 | $154.61 |
Target Met
|
$138.35
+15.0%
|
| Oct 31, 2024 |
Abbvie Inc
ABBV
|
BUY |
$228.00
Est. +13%
|
$201.50 | $244.81 |
Target Met
|
$263.25
+30.6%
|
| Oct 21, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$94.00
Est. +9%
|
$86.11 | $124.61 |
Target Met
|
$151.28
+75.7%
|
| Oct 21, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$566.00
Est. +17%
|
$485.74 | $519.88 |
Miss
|
$526.73
+8.4%
|
| Sep 25, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$362.00
Est. +9%
|
$330.92 | $335.88 |
Miss
|
$423.64
+28.0%
|
| Sep 23, 2024 |
Bristol-Myers Squibb Co.
BMY
|
SELL |
$48.00
Est. +3%
|
$49.56 | $42.99 (Low) |
Target Met
|
$62.86
-26.8%
|
| Sep 13, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$128.00
Est. +5%
|
$122.29 | $154.61 |
Target Met
|
$138.35
+13.1%
|
| Sep 12, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,300.00
Est. +12%
|
$1,159.95 | $1,170.58 |
Miss
|
$750.51
-35.3%
|
| Aug 09, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$85.00
Est. +12%
|
$75.59 | $121.38 |
Target Met
|
$151.28
+100.1%
|
| Aug 09, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,101.00
Est. +30%
|
$845.31 | $972.53 |
Miss
|
$1,186.10
+40.3%
|
| Aug 08, 2024 |
Novo Nordisk - ADR
NVO
|
BUY |
$160.00
Est. +27%
|
$126.17 | $139.74 |
Miss
|
$38.31
-69.6%
|
| Jun 17, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$70.00
Est. +53%
|
$45.80 | $68.73 |
Precision Hit (±3%)
|
$65.87
+43.8%
|
| Jun 03, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,082.00
Est. +9%
|
$992.47 | $1,211.20 |
Target Met
|
$750.51
-24.4%
|
| May 31, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$500.00
Est. +13%
|
$443.05 | $519.88 |
Target Met
|
$526.73
+18.9%
|
| May 30, 2024 |
Merck & Co Inc
MRK
|
BUY |
$148.00
Est. +16%
|
$127.71 | $129.93 |
Miss
|
$149.32
+16.9%
|
| May 23, 2024 |
Biogen Inc
BIIB
|
BUY |
$260.00
Est. +18%
|
$220.00 | $237.98 |
Miss
|
$227.07
+3.2%
|
| May 20, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$80.00
Est. +18%
|
$67.90 | $119.69 |
Target Met
|
$151.28
+122.8%
|
| May 03, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$355.00
Est. +28%
|
$278.39 | $346.85 |
Precision Hit (±3%)
|
$423.64
+52.2%
|
| Apr 30, 2024 |
Incyte Corp.
INCY
|
SELL |
$52.00
Est. +0%
|
$52.05 | $53.56 (Low) |
Precision Hit (±3%)
|
$123.20
-136.7%
|
| Apr 18, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$900.00
Est. +20%
|
$748.40 | $972.53 |
Target Met
|
$1,186.10
+58.5%
|
| Apr 12, 2024 |
Novo Nordisk - ADR
NVO
|
BUY |
$163.00
Est. +30%
|
$125.40 | $143.69 |
Miss
|
$38.31
-69.4%
|
| Apr 02, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$50.00
Est. +46%
|
$34.21 | $68.73 |
Target Met
|
$65.87
+92.5%
|
| Sep 28, 2022 |
Biogen Inc
BIIB
|
BUY |
$360.00
Est. +82%
|
$197.79 | - | - |
$227.07
+14.8%
|
| May 08, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$358.00
Est. +21%
|
$296.90 | - | - |
$1,186.10
+299.5%
|
| Apr 10, 2022 |
Merck & Co Inc
MRK
|
SELL |
$87.00
Est. +1%
|
$87.68 | - | - |
$149.32
-70.3%
|
| Mar 17, 2022 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$74.00
Est. +5%
|
$70.52 | - | - |
$62.86
-10.9%
|
| Feb 21, 2022 |
AMGEN Inc.
AMGN
|
BUY |
$240.00
Est. +9%
|
$220.77 | - | - |
$423.64
+91.9%
|
| Feb 13, 2022 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$780.00
Est. +22%
|
$638.41 | - | - |
$750.51
+17.6%
|